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Abstract 
Background: Although the burden of impaired renal function is rising in sub‑Saharan Africa (SSA), little is known 
about correlates of impaired renal function in the region. We determined factors associated with estimated glomeru‑
lar filtration rate (eGFR) and impaired renal function in HIV‑infected and HIV‑uninfected adults.
Methods: We undertook cross‑sectional analysis of data from 1947 adults at enrolment for a cohort study on dia‑
betes and associated complications in HIV patients in Mwanza, north‑western Tanzania. A structured questionnaire 
was used to collect data on sociodemography, smoking, alcohol, physical activity, antiretroviral therapy (ART) and 
anthropometry. We measured blood pressure, tested blood samples for creatinine, glucose and HIV, and performed 
Kato Katz for Schistosoma mansoni. Correlates of eGFR (mL/min/1.73  m2) and impaired renal function (eGFR< 60 mL/
min/1.73  m2) were determined using linear regression and logistic regression, respectively.
Results: 655 (34%) participants were HIV‑uninfected, 956 (49%) were ART‑naive HIV‑infected and 336 (17%) were 
HIV‑infected adults on ART. The mean age was 41 years (SD12) and majority (59%) were females. Overall, the mean 
eGFR was 113.6 mL/min/1.73  m2 but 111.2 mL/min/1.73  m2 in HIV‑uninfected, 109.7 mL/min/1.73  m2 in ART‑naive HIV‑
infected and 129.5 mL/min/1.73  m2 in HIV‑infected ART‑experienced adults, and respective prevalence of impaired 
renal function was 7.0, 5.7, 8.1 and 6.3%. Correlates of lower eGFR were increasing age, higher socioeconomic status, 
unhealthy alcohol drinking, higher body mass index and diabetes mellitus. Anaemia was associated with 1.9 (95% 
Confidence Interval (CI):1.2, 2.7, p = 0.001) higher odds of impaired renal function compared to no anaemia and this 
effect was modified by HIV status (p value 0.02 for interaction).
Conclusion: Impaired renal function is prevalent in this middle‑aged study population. Interventions for prevention 
of impaired renal function are needed in the study population with special focus in HIV‑infected adults and those with 
high socioeconomic status. Interventions targeting modifiable risk factors such as alcohol and weight reduction are 
warranted.
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Background
The growing epidemic of non-communicable disease 
(NCD) in sub-Saharan Africa (SSA) poses a significant 
burden to the health care system in the region where 
prevalence of infectious diseases particularly human 
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immunodeficiency virus (HIV) is still very high [1]. 
The relative contribution of impaired renal function to 
the global burden of disease significantly has increased 
with Disability-Adjusted Life Years attributable to 
chronic kidney disease rising by 42% between 1990 and 
2017 [2, 3]. Economic consequences related to impaired 
renal function are enormous [4] calling for urgent 
intervention measures.
Both infectious and non-infectious risk factors have 
been associated with impaired renal function in SSA. 
In this region where two thirds of the HIV-infected 
population lives [5], impaired renal function is pro-
jected to rise as consequences of the direct insult of 
HIV virus on the kidneys or adverse effects of antiret-
roviral therapy (ART) [6]. In addition, schistosomia-
sis is highly prevalent in SSA and has been associated 
with impaired renal function in many epidemiological 
studies [7]. Moreover, the rising lifestyle risk factors 
for NCD in SSA [1] could fuel impaired renal function 
to epidemic proportions in the near future [3]. Unlike 
high income countries where impaired renal function is 
more common in middle-aged and elderly people, and 
mainly driven by diabetes mellitus and associated with 
hypertension, impaired renal function in SSA occurs in 
relatively younger people and is mainly associated with 
hypertension and/or glomerulonephritis [8].
If recent genetic evidence is correct [9], hypertension 
may well be the first sign of underlying renal disease, 
and the context of onset of hypertension in a relatively 
young population in SSA then warrants a closer exami-
nation of kidney function markers. A high prevalence 
of hypertension and lifestyle risk factors for NCDs has 
been reported in north-western Tanzania and south-
ern Uganda and a substantial proportion of young 
adults had hypertension [10, 11]. Other risk factors for 
impaired renal function common in SSA such as HIV 
infection and schistosomiasis may play an important 
role but research data are limited. Few high quality 
studies have been conducted to determine the burden 
and risk factors for impaired renal function in SSA and 
majority of these studies used measurement of urine 
protein to assess renal function [12, 13]. In a popula-
tion-based survey in north-western Tanzania, increas-
ing age, physical inactivity and higher blood pressure 
were associated with lower estimated glomerular filtra-
tion rate (eGFR) but this study was not designed with 
sufficient power to determine the effect of HIV on 
impaired renal function and the role of schistosomiasis 
was not investigated [14]. High quality epidemiologi-
cal studies using eGFR to estimate renal function are 
therefore needed to inform preventive measures tai-
lored to curb prevailing risk factors for impaired renal 
function in SSA.
The aim of this study was to determine factors asso-
ciated with eGFR and impaired renal function in HIV-
infected and HIV-uninfected adults. We hypothesised 
that diabetes mellitus, hypertension and schistosomia-




We conducted a cross-sectional study using data col-
lected at enrolment visit for a cohort study on diabe-
tes and associated complications in HIV patients in 
Mwanza, north-western Tanzania locally referred to as 
the Chronic Infections, Co-morbidities and Diabetes in 
Africa (CICADA) study, registered at https:// clini caltr 
ials. gov as NCT03106480.
HIV-infected and HIV-uninfected adults (≥ 18 years) 
from three pre-determined groups were enrolled from 
October 2016 to November 2017. The first group includes 
adults from two previous studies in Mwanza: Nutrition, 
Diabetes and Pulmonary Tuberculosis (TB-NUT), and 
Nutritional Support for African Adults Starting Antiret-
roviral Therapy (NUSTART). TB-NUT registered at 
https:// clini caltr ials. gov as NCT00311298 was conducted 
from 2006 to 2009 [15–18] while NUSTART registered 
as PACTR201106000300631 at Pan African Clinical Trial 
registry was undertaken from 2011 to 2013 [19]. All HIV-
infected participants from these previous studies were 
already on ART. The second group of participants were 
HIV-infected ART-naïve adults from HIV care and treat-
ment clinics in Mwanza, and the third group were HIV-
uninfected adults from the residential neighbourhood of 
enrolled ART-naïve HIV-infected participants.
Recruitment of study participants
Participants’ recruitment procedures have been 
described in detail elsewhere [20]. Based on survival sta-
tus at the end of TB-NUT and NUSTART, individuals 
who were known to be alive were invited to join CICADA 
study through telephone contact or home visit. HIV-
infected adults who were about to start ART were iden-
tified from HIV care and treatment clinics in Mwanza 
and invited to join the study. A computer-generated ran-
dom list of 50% enrolled ART-naïve HIV-infected adults 
was used for random selection of HIV-uninfected adults 
for enrolment into the study. As described previously 
[20], a field worker visited the street/sub-village where 
the index HIV-infected adult lives. With the help of the 
street/sub-village leader, a complete list of households in 
the area was prepared. Thereafter, we randomly selected 
three households which were visited one by one until an 
eligible adult was found. In a situation where we did not 
find eligible adult in the first list of randomly selected 
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households, the process was repeated until an eligible 
participant was enrolled.
Potential participants were eligible to join the study if 
they were ≥ 18 years, resident in the study area and not 
planning to relocate within 3 years after enrolment. In 
addition, for ART naïve HIV-infected adults they should 
have been willing to start ART immediately after study 
enrolment. HIV-uninfected adults were enrolled if lived 
in the same street/sub-village, of same sex, within 5 years 
of age of the index HIV-infected adult, and tested nega-
tive for HIV using rapid tests as part of the study proce-
dures. Participants were excluded if they were pregnant 
or terminally ill.
After assessment for eligibility, potential participants 
were instructed to fast overnight on a scheduled study 
clinic appointment date for informed consent and pos-
sible study enrolment. One day before scheduled enrol-
ment visit, potential participants were contacted by 
telephone and reminded to come the following day after 
an overnight fast. Consenting participants were enrolled 
and underwent study procedures as described below.
Data collection
As previously described [20] we used a structured ques-
tionnaire adapted from STEPwise approach to chronic 
disease risk factor surveillance (STEPS) tool [21] to col-
lect data on socio demographic variables (i.e. age, sex, 
education), and risk factors for NCDs including physical 
inactivity, alcohol use and smoking. A clinical question-
naire was used to capture information on previous his-
tory of diabetes and hypertension and drug use for these 
conditions, and information on ART use was retrieved 
from participants’ clinical records.
We took three measurements for weight using digital 
scale and height using a stadiometer (Seca, Germany) 
and used their median values to calculate body mass 
index (BMI) as weight (kg)/(height(m))2. Using a body 
composition bio-impedance analyser (Tanita BC418, 
Tokyo, Japan), we measured fat mass (kg) and fat-free 
mass (kg) and computed fat mass index as fat mass (kg)/
(height(m))2 and fat-free mass index as fat-free mass 
(kg)/height (m))2. With the participant seated and the 
arm supported at the level of the heart, we used a digital 
blood pressure monitor (Omron Health Care Manufac-
turing Vietnam Co., Ltd., Binh Duong Province, Viet-
nam) with small, medium, or large cuff depending on 
mid upper arm circumference to measure blood pressure 
three times. We first measured blood pressure once on 
each arm and took a third measurement on the arm with 
highest blood pressure reading. The average of the three 
blood pressure readings was used in the analysis.
On arrival at the study clinic, and after confirmation 
of fasting status, we collected blood sample for serum 
creatinine, full blood count, blood glucose and HIV test-
ing (for participants with unknown HIV status), and 
stool samples for Schistosoma mansoni eggs. Partici-
pant underwent a standard oral glucose tolerance test 
(OGTT). After collection of fasting blood glucose sam-
ple, participants were asked to drink (within 5 min) a 
solution containing 75 g of glucose in 250 mL of drinking 
water. Another blood sample for glucose measurement 
was collected 120 min after oral administration of glucose 
solution. Blood glucose was measured at the study clinic 
using Hemocue Glucose 201 RT machine (Hemocue AB, 
Angelholm, Sweden). Laboratory samples for other tests 
were transported in a cool box to the National Institute 
for Medical Research (NIMR) laboratory in Mwanza 
within 2 h of collection for testing. NIMR laboratory par-
ticipates in external quality assurance programs including 
the Royal College of Pathologists of Australasia Quality 
Assurance Program.
Serum creatinine was performed using A25 biochem-
istry analyser (Biosystems S.A; Costa Brava, 30; 08030 
Barcelona; Spain) with modified Jaffe method traceable 
to isotope dilution mass spectrometry and full blood 
count was measured using Beckman Coulter AcT5diff 
AL haematology analyser (Beckman Coulter Inc. 11,800 
SW 147 Avenue, Miami, Florida 33,196–2500 USA). HIV 
tests were performed according to national guidelines 
using SD Bioline (SD HIV- 1/2 3.0SD standard diagnos-
tics Inc) and Unigold (The Uni-Gold, Trinity Biotech, 
IDA Business Park, Bray, Co. Wicklow, Ireland) rapid 
tests. Discordant results were analysed using the Uniform 
II vironostika-HIV Ag/Ab Micro-Elisa system (Biomer-
ieuxbv, The Netherlands). Schistosoma mansoni eggs 
were identified using Kato Katz technique.
Definitions
We measured renal function by calculating eGFR using 
the Chronic Kidney Disease Epidemiology (CKD-EPI) 
collaboration formula without a race correction factor 
since this correction factor has been reported to over-
estimate eGFR in African populations [22, 23]. Impaired 
renal function was defined according to Kidney Disease 
Improving Global Outcome (KDIGO) guidelines [24] 
as eGFR < 60 mL/min/1.73m2. We further categorised 
renal function according to KDIGO guidelines as fol-
lows: normal (≥ 90), mildly decreased (60–89), mildly 
to moderately decreased (45–59), moderately to severely 
decreased (30–44), severely decreased (15–29) and kid-
ney failure (< 15). Renal hyperfiltration was defined as 
eGFR > 135 mL/min/1.73m2 [25]. BMI (kg/m2) was cate-
gorised into three groups as underweight (< 18.5), normal 
weight (18.5 - < 25) and overweight/obesity (≥ 25). Anae-
mia was defined according to the World Health Organi-
zation (WHO) criteria as haemoglobin level < 12 mg/dL 
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for women and < 13 mg/dL for men [26]. Hypertension 
was defined as systolic blood pressure ≥ 140 mmHg and/
or diastolic blood pressure ≥ 90 mmHg or on medication 
for hypertension. Diabetes mellitus was defined accord-
ing to WHO guidelines [27] as 2 h oral glucose tolerance 
test blood glucose level ≥ 11.1 mmol/L or on medication 
for diabetes. Unhealthy alcohol drinking was defined 
as habitual alcohol drinking of more than two stand-
ard drinks/day for women or more than three standard 
drinks/day for men.
Data analysis
Data was analysed using Stata 14 data analysis software 
(College Station, Texas, USA). Participants’ background 
characteristics were described using frequencies and pro-
portions stratified by HIV status. Prevalence of impaired 
renal function and eGFR grades were also described 
using frequencies and proportion.
We used multivariable linear regression to assess the 
association between covariates with both eGFR as a con-
tinuous outcome (primary analysis) and impaired renal 
function defined by eGFR < 60 mL/min/1.73m2 (second-
ary analysis). All analyses were adjusted for age, sex and 
fat-free mass a priori. As participants may have very 
low muscle mass, which may lead to an overestimation 
of renal function by eGFR, we adjusted fat-free mass a 
priori. We used interaction terms for effect modifica-
tion in multivariable linear regression to test for effect 
modification by HIV status for all exposure variables. 
For any exposure variables with evidence of statistically 
significant effect modification by HIV status, we then 
determined the association between exposure variables 
and eGFR stratified by HIV status. In addition, we used 
logistic regression to determine factors associated with 
impaired renal function (eGFR < 60 mL/min/1.73m2) fol-
lowing similar steps as for linear regression. Associations 
were considered statistically significant if the p value was 
< 0.05.
Ethical considerations
The study was approved by the Medical Research Coor-
dinating Committee of the Tanzanian National Health 
Research Committee (Ref: NIMR/HQ/R.8a/Vol.IX/2264), 
the London School of Hygiene and Tropical Medicine 
ethics committee (LSHTM Ref. 11,989) and the National 
Committee on Health Research Ethics in Denmark (Case 
No.1608499). This analysis was part of PhD work for BK 
at the Catholic University of Health and Allied Sciences 
(CUHAS) in Tanzania. We therefore obtained an addi-
tional approval from CUHAS/Bugando Medical Centre 
joint ethics and review committee.
Results
Baseline characteristics
A total of 1947 participants were enrolled in the study 
of which 655 (34%) were HIV-uninfected, 956 (49%) 
were ART-naive HIV-infected and 336 (17%) were HIV-
infected on ART for median duration of 53 months 
(interquartile range (1QR) 46, 102) months). One hun-
dred and fifty nine (47%) participants on ART were using 
tenofovir diproxil fumarate containing ART regimen at 
the time of study enrolment. Participants’ enrolment flow 
chart has been previously described [20] and baseline 
characteristics are displayed in Table 1.The mean age was 
41 years (SD 12) and 59% were females. Only about 15% 
of enrolled participants had attained secondary or higher 
level of education. Cigarette smoking was common par-
ticularly in HIV-uninfected (9%) and HIV-infected ART-
naive participants (12%). A total of 596 (30%) reported 
current alcohol use and 556 (93%) of the current drinkers 
were unhealthy drinkers. Most study participants (> 80%) 
were physically active. Although the majority of par-
ticipants had normal BMI, underweight was common in 
HIV-infected groups (26–27%). Overall, 43% of the par-
ticipants had anaemia and this was more common (60%) 
in ART-naive HIV-infected adults. Up to 9% of the popu-
lation had Schistosoma mansoni, 12–28% had hyperten-
sion and the proportion with diabetes mellitus ranged 
from 4% in HIV-infected adults on ART to 9% in ART-
naive HIV-infected adults. Out of 128 participants with 
diabetes, 103 (81%) were newly diagnosed. The median 
duration of diabetes for the 25 known diabetic patients at 
study enrolment was 3 years (IQR: 1, 4).
Renal function
Table  2 describes renal function by HIV status. The 
results for eGFR were available for 1942 participants: 
654 HIV-uninfected, 955 ART-naive HIV-infected and 
333 HIV-infected on ART. The mean eGFR was highest 
(129.5 mL/min/1.73m2) in HIV-infected adults on ART 
followed by 111.2 mL/min/1.73m2 in the HIV-unin-
fected group and 109.7 mL/min/1.73m2 in ART-naive 
HIV-infected group. Although the HIV-infected adults 
on ART had a higher mean eGFR, this group also had a 
larger proportion of participants with severely impaired 
renal function i.e. moderately to severely (3%) and 
severely decreased (0.9%) renal function, and kidney fail-
ure (0.9%). Overall, six participants (0.3%) - three (0.3%) 
in the ART-naive HIV-infected group and three (0.9%) in 
HIV-infected adults on ART group had end stage kidney 
disease (eGFR < 15 mL/min/1.73m2). The proportion of 
participants with impaired renal function (eGFR < 60 mL/
min/1.73m2) ranged from 5.7% in HIV-uninfected group 
to 8.1% in the ART naive HIV-infected adults. Hyper-
filtration was most common (42%) in HIV-infected 
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Table 1 Characteristics of study participants by HIV and antiretroviral therapy (ART)  status1
1 Data are number (%) unless otherwise specified and for some variables the sum may not equal to column totals due to missing values; 2Standard deviation; 
3Socioeconomic status calculated using principal component analysis; 4Habitual alcohol drinking of more than two standard drinks for women or more than three 
standard drinks for men; 5Calculated as metabolic equivalents based on total time spent in moderate and vigorous intensity physical activity per week; 6Haemoglobin 
level < 12 mg/dL for women and < 13 mg/dL for men; 7Systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg or on medication for 
hypertension; 8Two hour oral glucose tolerance test blood glucose level ≥ 11.1 mmol/L or on medication for diabetes





HIV positive on ART 
(n = 336)
Age (years); mean (SD)2 1947 42.2 (13.2) 38.2 (10.9) 44.8 (10.1)
18–30 139 (21.2) 256 (26.8) 25 (7.4)
31–40 183 (27.9) 342 (35.8) 98 (29.2)
41–50 171 (26.1) 223 (23.3) 127 (37.8)
> 50 162 (24.7) 135 (14.1) 86 (25.6)
Sex, female 1947 371 (56.6) 577 (60.4) 209 (62.2)
Education level 1942
No formal education 80 (12.2) 158 (16.6) 81 (24.2)
Primary 426 (65.0) 676 (71.0) 224 (66.9)
Secondary/Tertiary 149 (22.8) 118 (12.4) 30 (9.0)
SES3 tertile 1942
Lower 167 (25.5) 316 (33.2) 165 (49.3)
Middle 220 (33.6) 328 (34.5) 99 (29.6)
Upper 268 (40.9) 308 (32.4) 71 (21.2)
Smoking 1942
Never smoked 507 (77.5) 727 (76.4) 240 (71.4)
Past smoked 89 (13.6) 116 (12.2) 81 (24.1)
Current smoker 58 (8.9) 109 (11.5) 15 (4.5)
Alcohol use 1942
Never 212 (32.4) 248 (26.1) 93 (27.7)
Ex‑drinker 231 (35.3) 376 (39.5) 186 (55.4)
Current moderate drinker 18 (2.8) 16 (1.7) 6 (1.8)
Current unhealthy  drinker4 193 (29.5) 312 (32.8) 51 (15.2)
Antiretroviral regimen 335
Tenofovir containing – – 159 (47.5)
Other regimen – – 176 (52.5)
Physically  inactive5 1941 82 (12.6) 137 (14.4) 51 (15.2)
Body mass index (kg/m2), mean (SD)2 1946 23.6 (4.9) 21.1 (4.1) 20.7 (3.7)
Underweight (< 18.5) 86 (13.1) 254 (26.6) 86 (25.6)
Normal (18.5 ‑ < 25) 351 (53.6) 565 (59.2) 214 (63.7)
Overweight/obesity (≥25) 218 (33.3) 136 (14.2) 36 (10.7)
Fat mass index (kg/m2), mean (SD)2 1900 6.3 (4.0) 4.6 (3.4) 4.5 (3.1)
Fat‑free mass index (kg/m2) 1900 17.1 (1.9) 16.3 (1.8) 16.0 (1.6)
Haemoglobin level (g/dL), mean (SD)2 1942 13.5 (2.0) 11.5 (2.4) 12.6 (1.9)
Anemia6 127 (19.5) 577 (60.4) 124 (37.0)
S. mansoni egg(s) seen 1768 50 (8.5) 72 (8.2) 19 (6.2)
Systolic blood pressure (mmHg), mean (SD)2 125.7 (20.5) 112.6 (18.0) 110.2 (18.9)
Diastolic blood pressure (mmHg), mean (SD)2 81.7 (12.3) 75.6 (11.7) 74.1 (11.9)
Hypertension7 1943 182 (27.8) 127 (13.3) 39 (11.7)
Diabetes  Mellitus8 1941
Normal (≤ 7.7 mmol/L) 378 (58.1) 417 (43.7) 172 (51.3)
Prediabetes (7.8–11.0 mmol/L) 246 (37.8) 449 (47.0) 151 (45.1)
Diabetes (≥ 11.1 mmol/L) 27 (4.2) 89 (9.3) 12 (3.6)
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adults on ART and 65 (46%) out of 141 hyperfiltrating 
HIV-infected adults on ART were on tenofovir diproxil 
fumarate. Of those who were on a tenofovir containing 
regimen, 65 (41.1%) had hyperfiltration vs 76 (43.7%) 
who were on other ART regimens.
Factors associated with eGFR and impaired renal function
Correlates of eGFR from linear regression model 
adjusted for age, sex and fat-free mass are presented in 
Table  3. Factors associated with lower eGFR were older 
age, higher level of education, higher socioeconomic sta-
tus, unhealthy alcohol drinking, higher BMI and diabe-
tes mellitus. Male sex and being HIV-infected on ART 
were associated with higher eGFR. One year increase in 
age was associated with 0.3 mL/min/1.73m2 lower eGFR 
(95% Confidence interval (CI):-0.4, − 0.1; p = 0.001). 
Having completed primary school was associated with 
7.5 mL/min/1.73m2 (95% CI: − 12.8, − 2.2, p = 0.005) 
lower eGFR and those with secondary to tertiary level of 
education had 7.6 mL/min/1.73m2 (95% CI: − 14.6, − 0.7, 
p = 0.03) lower eGFR compared to no formal education 
group. The eGFR was lower by 7.0 mL/min/1.73m2 (95% 
CI: − 11.8, − 2.3, p = 0.004) in the upper socioeconomic 
tertile compared to lower socioeconomic tertile and 
unhealthy alcohol drinking was associated with 4.7 mL/
min/1.73m2 (95% CI: − 9.0, − 0.4, p = 0.03) lower eGFR 
compared to non-alcohol drinkers. One unit increase in 
BMI was associated with 0.58 mL/min/1.73m2 (95% CI:-
1.16, − 0.01, p = 0.047) lower eGFR and diabetes mellitus 
was associated with 11.2 mL/min/1.73m2 (95% CI: − 19.3, 
− 3.2, p = 0.006) lower eGFR compared to non diabetic. 
Male sex was associated with 13.0 (95% CI: 7.7, 18.2, 
p <   0.001) higher eGFR compared to females and being 
HIV-infected on ART was associated with 18.3 (95% CI: 
12.8, 23.9, p <   0.001) higher eGFR compared to HIV-
uninfected individuals. Anaemia, blood pressure and 
presence of Schistosoma mansoni eggs were not associ-
ated with eGFR.
Table 4 summarizes correlates of impaired renal func-
tion using logistic regression model adjusted for age 
sex and fat-free mass. The only factors associated with 
impaired renal function were diabetes mellitus and anae-
mia. Being anaemic was associated with almost two times 
higher odds of impaired renal function compared to non-
anaemic individuals - adjusted odds ratio (aOR) 1.9 (95% 
CI: 1.3, 2.7; p = 0.001) and being diabetic was associated 
with more than twofold increase in odds of impaired 
renal function compared to non diabetics - aOR 2.4 (95% 
CI: 1.4, 4.4; p = 0.003). Age, sex, BMI, blood pressure, and 
presence of Schistosoma mansoni eggs were not associ-
ated with impaired renal function.
Effect modification in the relationship between HIV status 
and eGFR
HIV status modified the effect of haemoglobin level on 
eGFR (p value 0.02 - Table 3). With all participants com-
bined, haemoglobin level was not associated with eGFR 
levels in linear regression model. However, when strati-
fied by HIV status, one unit increase in haemoglobin 
was associated with − 3.4 (95%CI: − 5.2, − 1.7) lower 
eGFR in HIV-uninfected adults but was not associated 
with eGFR in HIV-infected adults. Overall, being anae-
mic was associated with almost twofold higher odds 
of impaired renal function (95% CI: 1.2, 2.7, p = 0.001) 
Table 2 Estimated glomerular filtration rate by HIV and antiretroviral therapy (ART) status
1 Missing eGFR results: One in HIV-uninfected, one in ART-naive HIV-infected and three in HIV-infected on ART; 2Comparing ART-naive HIV-infected with HIV-
uninfected group; 3Comparing HIV-infected on ART with ART-naive HIV-infected group; 4Comparing HIV-infected on ART with HIV-uninfected group; 5Standard 
deviation; 6Renal hyper filtration







p*  value2 HIV-infected on ART 
(n = 333)1
p*  value3 p*  value4
eGFR (ml/min/1.73m2), mean (SD)5 111.2 (37.6) 109.7 (35.3) 0.06 129.5 (59.6) < 0.001 < 0.001
Impaired renal function (eGFR< 60 mL/min/1.73m2), n (%) 37 (5.7) 77 (8.1) 0.045 21 (6.3) 0.20 0.76
eGFR categories (in eGFR > 135 mL/min/1.73m2)
 High normal (> 135)6 173 (26.5) 257 (26.9) 0.73 141 (42.3) < 0.001 < 0.001
  Normal (90–135) 300 (45.9) 417 (43.7) 127 (38.1)
  Mildly decreased (60–89) 144 (22.0) 204 (21.4) 44 (13.2)
  Mildly to moderately decreased (45–59) 26 (4.0) 50 (5.2) 5 (1.5)
  Moderately to severely decreased (30–44) 8 (1.2) 17 (1.8) 10 (3.0)
  Severely decreased (15–29) 3 (0.5) 7 (0.7) 3 (0.9)
  Kidney failure (< 15) 0 (0.0) 3 (0.3) 3 (0.9)
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Table 3 Factors associated with  eGFR1 in HIV‑infected and HIV‑uninfected adults
Characteristic n Mean  eGFR1 Adjusted  coefficients2 (95%  CI3) p  value4 p value for 
interaction*
Age (years) 1942 113.6 − 0.3 (− 0.4, − 0.1) 0.001 0.25
Sex 0.51
Female 1156 111.4 0
Male 786 116.7 13.0 (7.7, 18.2) < 0.001
HIV status
HIV‑uninfected 654 111.2 0
HIV‑infected ART‑naive 955 109.7 −4.1 (−8.4, 0.1) 0.06
HIV‑infected on ART 333 129.5 18.3 (12.8, 23.9) < 0.001
Education level 0.20
No formal education 317 119.1 0
Primary 1323 112.3 −7.5 (−12.8, −2.2) 0.005
Secondary/Tertiary 297 113.5 −7.6 (− 14.6, −0.7) 0.03
SES5 tertiles 0.73
Lower 644 116.9 0
Middle 646 114.6 −2.4 (−7.0, 2.3) 0.32
Upper 647 109.3 −7.0 (−11.8, −2.3) 0.004
Smoking 0.20
Never smoked 1471 112.9 0
Past smoked 285 116.3 2.2 (−3.9, 8.3) 0.48
Current smoker 181 115.1 −1.4 (−8.8, 5.9) 0.71
Alcohol use 0.16
Non drinker 1342 114.6 0
Current moderate drinker 40 121.9 7.2 (−6.1, 20.5) 0.29
Current unhealthy  drinker6 555 110.7 −4.7 (−9.0, −0.4) 0.03
Antiretroviral regimen
Tenofovir containing 174 130.4 0
Other regimen 158 128.8 −2.7 (−15.6, 10.3) 0.69
Physical activity (minutes/week)7 0.06
Active (≥ 600) 1667 113.0 0
Inactive (<  600) 229 117.2 4.4 (−1.3, 10.0) 0.13
Body mass index (kg/m2) 1941 113.6 −0.58 (−1.16, − 0.01) 0.047 0.31
Underweight (< 18.5) 423 118.6 2.9 (−2.3, 8.1) 0.28
Normal (18.5 ‑ < 25) 1128 114.2 0
Overweight/obesity (≥25) 390 106.4 −3.2 (−8.6, 2.2) 0.25
Haemoglobin (g/dL) 1938 113.5 0.3 (−0.6, 1.2) 0.46 0.02
Normal 1112 113.9 0
Anaemia8 826 113.1 −1.9 (−5.8, 2.0) 0.34
S. mansoni egg(s) seen 0.34
No 1623 113.9 0
Yes 141 114.7 −1.2 (−8.6, 6.2) 0.76
Systolic blood pressure (mmHg) 1938 113.7 −0.02 (−0.12, 0.08) 0.73 0.97
Diastolic blood pressure (mmHg) 1938 113.7 −0.1 (− 0.2, 0.1) 0.40 0.39
Hypertension9 0.91
No 1590 114.6 0
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compared to non-anaemic individuals (Table  4) but in 
the stratified analysis this association was only observed 
in ART-naive HIV-infected group - aOR 2.1 (95% CI: 1.2, 
3.6, p = 0.007). We present all correlates of eGFR (Addi-
tional  file  1) and correlates of impaired renal function 
(Additional file 2) by HIV status.
Discussion
We report a non-ignorable prevalence (7%) of impaired 
renal function (eGFR < 60 mL/min/1.73m2) in a relatively 
young population of HIV-infected and HIV-uninfected 
adults in north-western Tanzania. Moderate to severely 
impaired renal function was particularly common in 
HIV-infected adults, occurring in 2.8% of ART-naive 
HIV-infected adults and 4.8% of HIV-infected adults on 
ART. HIV-infected adults on ART had higher mean eGFR 
than both HIV-uninfected and ART-naive HIV-infected 
adults, but this difference was driven by the higher pro-
portion of eGFR values that were > 135 mL/min/1.73m2 
in HIV-infected adults on ART. Correlates of lower eGFR 
were older age, higher education level, higher socioeco-
nomic status, unhealthy alcohol drinking and diabetes 
mellitus. Anaemia was associated with higher odds of 
impaired renal function.
To put this in context, this level of prevalence of 
impaired kidney function is usually seen in populations 
aged 50 or more years in high-income settings [28], and 
our study suggest that impaired kidney function has the 
same prevalence in people who are on average 10 years 
younger in SSA. Our study reports higher prevalence of 
impaired renal function in HIV-infected compared to 
HIV-uninfected adults. In line with general population-
based epidemiological studies in SSA [14, 29], we found 
statistically significant higher prevalence of impaired 
renal function in ART-naive HIV-infected compared to 
HIV-uninfected adults; this could be due to HIV-asso-
ciated nephropathy [6, 30]. In addition, compared to 
ART-naive HIV infected adults, HIV-infected adults on 
ART had lower prevalence of impaired renal function 
(eGFR < 60 mL/min/1.73m2), although the difference did 
not reach statistical significance. On the other hand, the 
prevalence of moderately-severely impaired renal func-
tion (eGFR < 45 mL/min/1.73m2) was higher in HIV-
infected adults on ART (4.8% vs. 2.8% in ART-naive 
HIV-infected and 1.7% in HIV-uninfected groups). 
These findings are in line with existing literature where 
modern tenofovir-based ART has been reported to 
improve renal function in most patients [31, 32], while 
leading to progression of kidney disease in others 
[33–35].
The mean eGFR was higher in HIV-infected adults 
on ART compared to both HIV-uninfected adults and 
ART-naive HIV-infected adults. This difference in mean 
eGFR was driven by the large proportion of HIV-infected 
adults on ART with eGFR greater than 135 mL/min/
m2. Of note, as is the case in most of SSA, 46% of ART-
experienced HIV-infected participants with hyperfiltra-
tion were receiving ART regimens containing tenofovir 
diproxil fumarate. Tenofovir has been shown to cause 
renal hyperfiltration in African adults with HIV [34, 35]. 
Renal hyperfiltration, in turn, is associated with more 
rapid progression of kidney disease in HIV-infected 
adults on tenofovir [34] as well as cardiovascular disease 
[36]. In long run, the overall renal benefit of HIV viral 
suppression in improving HIV associated nephropathy 
could therefore be outweighed by nephrotoxic effects of 
tenofovir containing ART in populations at high risk for 
kidney disease. The significance of this finding remains 
unclear and deserves further investigation in prospective 
cohort studies.
In our study, higher socioeconomic status and higher 
educational achievement were associated with lower 
eGFR. These finding differs from reports in studies con-
ducted in high income countries where indicators of 
higher socioeconomic status have been associated with 
higher eGFR and less impaired renal function [37–39]. 
1 Estimated glomerular filtration rate (mL/min/1.73m2); 2Adjusted for age sex and fat-free mass; 3Confidence interval; 4p-value for 2 tailored t test; 5Socioeconomic 
status calculated using principal component analysis; 6Habitual alcohol drinking of more than two standard drinks for women or more than three standard drinks for 
men; 7Metabolic equivalent - calculations based on total time spent in moderate and vigorous intensity physical activity per week; 8Haemoglobin level < 12 mg/dL for 
women and < 13 mg/dL for men; 9Systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg or on medication for hypertension; 10Two hour oral 
glucose tolerance test blood glucose level ≥ 11.1 mmol/L or on medication for diabetes
*p-value (Wald test) for interaction with HIV status
Characteristic n Mean  eGFR1 Adjusted  coefficients2 (95%  CI3) p  value4 p value for 
interaction*
Yes 348 109.4 −1.7 (−6.8, 3.4) 0.52
Diabetes  Mellitus10 0.36
Normal (≤ 7.7) 965 112.8 0
Prediabetes (7.8–11.0) 844 115.9 3.0 (−0.9, 6.9) 0.14
Diabetes (≥ 11.1) 128 103.5 −10.2 (−18.2, −2.3) 0.01
Table 3 (continued)
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Table 4 Factors associated with impaired renal function in HIV‑infected and HIV‑uninfected adults
n Impaired renal  function1 n (%) aOR2 (95%  CI3) p  value4
Age categories (years)
  18–30 420 26 (6.2) 0
  31–40 621 49 (7.9) 1.3 (0.8, 2.1) 0.32
  41–50 519 32 (6.2) 1.0 (0.6, 1.7) 0.98
> 50 382 28 (7.3) 1.2 (0.7, 2.2) 0.44
Sex
  Female 1156 82 (7.1) 0
  Male 786 53 (6.7) 1.0 (0.6, 1.6) 0.88
HIV status
  HIV‑uninfected 654 37 (5.7) 0
  HIV‑infected ART‑naive 955 77 (8.1) 1.5 (1.0, 2.3) 0.048
  HIV‑infected on ART 333 21 (6.3) 1.1 (0.6, 1.9) 0.75
Education level
  No formal education 317 17 (5.4) 0
  Primary 1323 96 (7.3) 1.5 (0.9, 2.5) 0.17
  Secondary/Tertiary 297 21 (7.1) 1.5 (0.7, 3.0) 0.24
SES5tertiles
  Lower 644 46 (7.1) 0
  Middle 646 41 (6.4) 0.9 (0.6, 1.4) 0.62
  Upper 647 47 (7.3) 1.0 (0.7, 1.6) 0.95
Smoking
  Never smoked 1471 99 (6.7) 0
  Past smoked 285 22 (7.7) 1.2 (0.7, 2.1) 0.51
  Current smoker 181 13 (7.2) 1.3 (0.6, 2.5) 0.51
Alcohol use
  Non drinker 1342 92 (6.9) 0
 Current moderate drinker 40 2 (5.0) 0.7 (0.2, 3.1) 0.68
  Unhealthy  drinker6 555 40 (7.2) 1.1 (0.7, 1.6) 0.61
Antiretroviral regimen
  Tenofovir containing 174 7 (4.0) 0
  Other regimen 158 13 (8.2) 2.1 (0.8, 5.6) 0.12
Physical activity (minutes/week)7
  Active (≥ 600) 1667 110 (6.6) 0
  Inactive (<  600) 269 24 (8.9) 1.4 (0.9, 2.2) 0.20
Body mass index (kg/m2)
  Underweight (< 18.5) 423 29 (6.9) 1.0 (0.6, 1.6) 0.89
  Normal (18.5‑ < 25) 1128 79 (7.0) 0
  Overweight/obesity (≥25) 390 26 (6.7) 0.9 (0.6, 1.5) 0.76
Anaemia8
  No 1112 60 (5.4) 0
  Yes 826 75 (9.1) 1.9 (1.3, 2.7) 0.001
S. mansoniegg(s) seen
  No 1623 118 (7.3) 0
  Yes 141 8 (5.7) 0.8 (0.4, 1.7) 0.60
Hypertension9
  No 1590 109 (6.9) 0
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Findings from the ARIC study in the United States 
showed that individuals with less than high school edu-
cation had almost two times higher odds of impaired 
renal function compared to those with college educa-
tion [40] and similar findings have been reported in 
other studies conducted in Europe [41, 42]. A recent 
meta-analysis confirmed the association between lower 
income and education with kidney disease, but noted 
that data are scarce in SSA [38]. Our own population 
based study in Tanzania previously demonstrated a link 
between higher socioeconomic status and kidney disease 
[14], a finding that we have now confirmed in this study. 
The association between high socioeconomic status and 
kidney disease in Africa could be mediated through obe-
sity which is more common in wealthier households 
in Africa [43]. In our study, 33% of participants in the 
higher socioeconomic status were overweight or obese 
compared to about 10% in the lower socioeconomic 
status group, and almost all overweight or obese partic-
ipants were females and females had lower eGFR com-
pared to males.
Diabetes mellitus was associated with lower eGFR 
and with higher odds of impaired renal function. 
These findings are consistent with available body of 
literature globally. Diabetes mellitus typically leads to 
hyperfiltration and then progresses to reduced eGFR. 
This association between diabetes and reduced eGFR 
in our study is notable, because nearly 81% of study 
participants were newly diagnosed with diabetes mel-
litus at the time of study enrolment. Very often, dia-
betes mellitus is an asymptomatic condition and may 
go unnoticed in many people until they present with 
chronic complications. Therefore, it appears likely that 
the diabetes mellitus may have been present but undi-
agnosed for many years prior to study enrolment. This 
is typically true in SSA context where health systems 
are not always well-equipped for NCD care including 
diabetes mellitus [44, 45] and routine screening for 
diabetes is rarely done [46].
Anemia was associated with almost twofold higher odds 
of impaired renal function compared to no anemia. These 
findings are in line with medical literature. Kidney disease 
can cause anemia due to reduced levels of erythropoietin 
levels [47]. Interestingly, the relationship between haemo-
globin level and eGFR differed by HIV status.
As with any study, our study has limitations. Given 
the cross-sectional design, it is not possible to establish 
causal link between exposures of interest and impaired 
renal function. In addition, participants recruited from 
NUSTART and TBNUT cohorts largely represent survi-
vors due to high mortality rate during the original studies 
[19] and therefore our estimates for impaired renal func-
tion and observed risk profile could be influenced by sur-
vival bias.
Conclusion and recommendations
Impaired renal function is high in the study popula-
tion especially in ART-naive HIV-infected adults. Inter-
ventions for prevention of impaired renal function are 
needed in the study population with special focus in 
HIV-infected adults and those with high socioeconomic 
status. Interventions on modifiable risk factors such as 
alcohol and weight reduction are warranted in this popu-
lation. Future research should focus on the consequences 
of hyperfiltration in HIV-infected adults on tenofovir-
containing ART.
Abbreviations
aOR: Adjusted odds ratio; BP: Blood Pressure; ART : Antiretroviral therapy; BMI: 
Body mass index; CICADA: Chronic Infections, Co‑morbidities and Diabetes in 
Africa; CKD‑EPI: Chronic Kidney Disease Epidemiology; CUHAS: Catholic Uni‑
versity of Health and Allied Sciences; eGFR: Estimated glomerular filtration rate; 
HIV: Human immunodeficiency virus; 1QR: Interquartile range; KDIGO: Kidney 
Disease Improving Global Outcome; NCD: Non‑communicable disease; NIMR: 
National Institute for Medical Research; NUSTART : Nutritional Support for African 
Adults Starting Antiretroviral Therapy; OGTT : Oral glucose tolerance test; SES: 
Socioeconomic status; SSA: Sub‑Saharan Africa; SD: Standard deviation; STEPS: 
STEPwise approach to chronic disease risk factor surveillance; TB‑NUT: Nutrition, 
Diabetes and Pulmonary Tuberculosis; WHO: World Health Organization.
1 Estimated glomerular filtration rate < 60 mL/min/1.73m2); 2Adjusted odds ratio - adjusted for age sex and fat-free mass index; 3Confidence interval; 4p-value for 2 
tailored Wald test; 5Socioeconomic status calculated using principal component analysis; 6Habitual alcohol drinking of more than two standard drinks for women 
or more than three standard drinks for men; 7Metabolic equivalent - calculations based on total time spent in moderate and vigorous intensity physical activity per 
week; 8Haemoglobin level < 12 mg/dL for women and < 13 mg/dL for men; 9Systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg or on 
medication for hypertension; 10Two hour oral glucose tolerance test blood glucose level ≥ 11.1 mmol/L or on medication for diabetes
n Impaired renal  function1 n (%) aOR2 (95%  CI3) p  value4
  Yes 348 24 (6.9) 1.0 (0.6, 1.6) 0.95
Diabetes  Mellitus10
  Normal (≤ 7.7) 965 61 (6.3) 0
  Prediabetes (7.8–11.0) 844 56 (6.6) 1.1 (0.7, 1.6) 0.72
  Diabetes (≥ 11.1) 128 18 (14.1) 2.3 (1.3, 4.2) 0.004
Table 4 (continued)
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